Literature DB >> 16791266

Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotype.

V Bardet, L D Costa, C Elie, S Malinge, C Demur, J Tamburini, P C Lefebvre, F Witz, B Lioure, E Jourdan, A Pigneux, N Ifrah, M Attal, F Dreyfus, P Mayeux, C Lacombe, A Bennaceur-Griscelli, O A Bernard, D Bouscary, C Récher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16791266     DOI： 10.1038/sj.leu.2404294

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis.

Authors:  Sergej Konoplev; Xuelin Huang; Harry A Drabkin; Hartmut Koeppen; Dan Jones; Hagop M Kantarjian; Guillermo Garcia-Manero; Weina Chen; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

2.  Rapid method for detection of mutations in the nucleophosmin gene in acute myeloid leukemia.

Authors:  Todd S Laughlin; Michael W Becker; Jane L Liesveld; Deborah A Mulford; Camille N Abboud; Patrick Brown; Paul G Rothberg
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.